Univercells Technologies is a brand that specializes in delivering the next generation of bioprocess technologies. They are dedicated to revolutionizing the field of biomanufacturing by leveraging the strengths of process intensification and chaining. With a focus on innovation and cost-effectiveness, Univercells Technologies offers a range of products and services.

Their product lineup includes scale-X™ hydro, scale-X™ carbo, and scale-X™ cell collect, which are innovative and scalable bioreactor technologies for viral production. They also provide NevoLine™, an integrated upstream platform that offers an automated and intensified solution for virus manufacturing. Univercells Technologies is committed to providing reliable and scalable processing solutions.

Their white papers and application notes highlight the use of small-scale parallel bioreactor systems and continuous biomass estimation in fixed-bed bioreactors, leading to increased production capacity and quality. Through their customer testimonials, it is evident that Univercells Technologies is trusted by industry professionals. From lentiviral vectors to viral vectors and nucleic acids production, they have successfully supported manufacturing success in various areas.

In 2023, Univercells Technologies was acquired by Donaldson Company, Inc., further expanding their reach in the life sciences industry. Discover the next evolution of biomanufacturing with Univercells Technologies